Published in

Nature Research, Nature Communications, 1(11), 2020

DOI: 10.1038/s41467-020-19615-x

Links

Tools

Export citation

Search in Google Scholar

Epigenome-wide meta-analysis of PTSD across 10 military and civilian cohorts identifies methylation changes in AHRR.

Journal article published in 2020 by Alicia K. Smith, Adam X. Maihofer, Robert K. Naviaux, Andrew Ratanatharathorn, Allison E. Aiello, Ananda B. Amstadter, Allison E. Ashley-Koch ORCID, Dewleen G. Baker, Jean C. Beckham, Marco P. Boks, Sandro Galea, Melanie E. Garrett, Elbert Geuze, Guia Guffanti, Bart P. F. Rutten and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

AbstractEpigenetic differences may help to distinguish between PTSD cases and trauma-exposed controls. Here, we describe the results of the largest DNA methylation meta-analysis of PTSD to date. Ten cohorts, military and civilian, contribute blood-derived DNA methylation data from 1,896 PTSD cases and trauma-exposed controls. Four CpG sites within the aryl-hydrocarbon receptor repressor (AHRR) associate with PTSD after adjustment for multiple comparisons, with lower DNA methylation in PTSD cases relative to controls. Although AHRR methylation is known to associate with smoking, the AHRR association with PTSD is most pronounced in non-smokers, suggesting the result was independent of smoking status. Evaluation of metabolomics data reveals that AHRR methylation associated with kynurenine levels, which are lower among subjects with PTSD. This study supports epigenetic differences in those with PTSD and suggests a role for decreased kynurenine as a contributor to immune dysregulation in PTSD.